MedTrace Logo

Robotic Evaluations of Motor Learning During Stroke Neurorehabilitation

NCT05106140 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-11-03

No results posted yet for this study

Summary

The RELEARN trial is a a prospective longitudinal cohort study sampled by convenience. Stroke survivors and healthy control individuals will be recruited to analyze motor learning in the upper extremity and its neural basis in early stroke recovery.

Conditions

Interventions

OTHER

Magnetic Resonance Imaging (MRI)

A research MRI will be performed at 6-weeks post-stroke to document stroke lesion location and size.

DEVICE

Kinarm Robotic Exoskeleton Assessment

The Kinarm Robotic Exoskeleton is a device used to provide therapy and assessment. The device has framework that supports the arms and these supports are adjustable to ensure a comfortable fit. Motors attached to the framework move the arms and record shoulder and elbow movements. The assessment involves performing a number of tasks using the Kinarm to measure proprioceptive and motor impairment, adaptation to force and visual disturbances, and retention after 24 hours.

OTHER

Clinical Assessment

The clinical assessment will be performed by a qualified stroke therapist and include a number of verified measurements to examine: reflexes, strength, apraxia, somatosensation, physical abilities, and cognition.

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • University of Calgary

    lead OTHER

Principal Investigators

  • Tyler Cluff, PhD · University of Calgary, Calgary, Alberta, Canada

  • Sean Dukelow, MD PhD FRCPC · University of Calgary, Calgary, Alberta, Canada

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-20
Primary Completion
2026-09-01
Completion
2026-09-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05106140 on ClinicalTrials.gov